Viewing Study NCT02982720


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-03-11 @ 11:06 PM
Study NCT ID: NCT02982720
Status: TERMINATED
Last Update Posted: 2022-02-16
First Post: 2016-12-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
Sponsor: Aiwu Ruth He, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cholangiocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cholangiocarcinoma View
None Pembrolizumab View
None MK-3475 View
None Sylatron View
None peginterferon alfa-2b View